Onconova Therapeutics, Inc. (ONTX): Price and Financial Metrics


Onconova Therapeutics, Inc. (ONTX): $1.18

0.04 (+3.51%)

POWR Rating

Component Grades

Growth

S

Value

I

Momentum

G

Stability

N

Sentiment

U

Quality

P

Add ONTX to Watchlist
Sign Up

Industry: Biotech


Ranked

of

in industry

ONTX Stock Summary

  • ONTX has a market capitalization of $24,692,671 -- more than approximately merely 7.67% of US stocks.
  • For ONTX, its debt to operating expenses ratio is greater than that reported by just 0.48% of US equities we're observing.
  • With a price/sales ratio of 109.26, ONCONOVA THERAPEUTICS INC has a higher such ratio than 97.59% of stocks in our set.
  • If you're looking for stocks that are quantitatively similar to ONCONOVA THERAPEUTICS INC, a group of peers worth examining would be NVCN, KOPN, XBIO, HCWB, and KLIC.
  • ONTX's SEC filings can be seen here. And to visit ONCONOVA THERAPEUTICS INC's official web site, go to www.onconova.com.

ONTX Valuation Summary

  • ONTX's EV/EBIT ratio is 1.1; this is 89.16% lower than that of the median Healthcare stock.
  • ONTX's price/sales ratio has moved up 94.9 over the prior 116 months.

Below are key valuation metrics over time for ONTX.

Stock Date P/S P/B P/E EV/EBIT
ONTX 2023-01-30 103.5 0.7 -1.4 1.1
ONTX 2023-01-27 78.8 0.5 -1.0 1.4
ONTX 2023-01-26 80.1 0.5 -1.0 1.4
ONTX 2023-01-25 77.4 0.5 -1.0 1.5
ONTX 2023-01-24 77.9 0.5 -1.0 1.4
ONTX 2023-01-23 80.5 0.5 -1.1 1.4

ONTX Growth Metrics

    Its 3 year price growth rate is now at -98.15%.
  • Its 4 year net cashflow from operations growth rate is now at -19.68%.
  • Its 2 year cash and equivalents growth rate is now at 63.57%.
ONTX's revenue has moved down $4,056,000 over the prior 67 months.

The table below shows ONTX's growth in key financial areas (numbers in millions of US dollars).

Date Revenue Operating Cash Flow Net Income to Common Stock
2022-09-30 0.226 -16.675 -17.308
2022-06-30 0.226 -17.042 -15.363
2022-03-31 0.226 -17.135 -15.57
2021-12-31 0.226 -19.487 -16.163
2021-09-30 0.227 -20.69 -18.828
2021-06-30 0.236 -22.186 -21.616

ONTX's Quality Factors

The “Quality” component of the POWR Ratings focuses on 31 different factors of a companies fundamentals and operational strength. Here are some key insights as we drill into the specifics of these quality attributes.
  • ONTX has a Quality Grade of D, ranking ahead of 8.68% of graded US stocks.
  • ONTX's asset turnover comes in at 0.007 -- ranking 403rd of 682 Pharmaceutical Products stocks.
  • IDRA, MYMD, and CAPR are the stocks whose asset turnover ratios are most correlated with ONTX.

The table below shows ONTX's key quality metrics over time.

Period Asset Turnover Gross Margin ROIC
2021-06-30 0.007 1 2.820
2021-03-31 0.008 1 3.136
2020-12-31 0.009 1 3.246
2020-09-30 0.007 1 3.342
2020-06-30 0.009 1 3.259
2020-03-31 0.123 1 2.890

ONTX Price Target

For more insight on analysts targets of ONTX, see our ONTX price target page. And for a list of of all stocks sorted by upside potential based on analyst target price, see our Top Price Target page.

Average Price Target $0.30 Average Broker Recommendation 1.5 (Moderate Buy)

ONTX Stock Price Chart Interactive Chart >

Price chart for ONTX

ONTX Price/Volume Stats

Current price $1.18 52-week high $2.04
Prev. close $1.14 52-week low $0.62
Day low $1.11 Volume 164,600
Day high $1.23 Avg. volume 289,217
50-day MA $0.82 Dividend yield N/A
200-day MA $1.04 Market Cap 24.66M

Onconova Therapeutics, Inc. (ONTX) Company Bio


Onconova Therapeutics, Inc. is a clinical-stage biopharmaceutical company focused on discovering and developing novel small molecule drug candidates to treat cancer.


ONTX Latest News Stream


Event/Time News Detail
Loading, please wait...

ONTX Latest Social Stream


Loading social stream, please wait...

View Full ONTX Social Stream

Latest ONTX News From Around the Web

Below are the latest news stories about ONCONOVA THERAPEUTICS INC that investors may wish to consider to help them evaluate ONTX as an investment opportunity.

We Think Onconova Therapeutics (NASDAQ:ONTX) Needs To Drive Business Growth Carefully

Just because a business does not make any money, does not mean that the stock will go down. For example, although...

Yahoo | February 6, 2023

Onconova Therapeutics to Present at the 2023 Guggenheim Oncology Conference

NEWTOWN, Pa., Feb. 01, 2023 (GLOBE NEWSWIRE) -- Onconova Therapeutics, Inc. (NASDAQ: ONTX), (“Onconova”), a clinical-stage biopharmaceutical company focused on discovering and developing novel products for patients with cancer, today announced that the Company will be participating in the 2023 Guggenheim Oncology Conference taking place February 8-9, 2023 in New York City.

GlobeNewswire | February 1, 2023

Powerful stocks to Increase Your Investments: Onconova Therapeutics, Inc. (NASDAQ:ONTX 31.61%), National CineMedia, Inc. (NASDAQ:NCMI -11.99%)

ONTX has seen its SMA50 which is now 42.94%. In looking the SMA 200 we see that the stock has seen a 6.45%. NCMI has seen its SMA50 which is … The post Powerful stocks to Increase Your Investments: Onconova Therapeutics, Inc. (NASDAQ:ONTX 31.61%), National CineMedia, Inc. (NASDAQ:NCMI -11.99%) appeared first on Stocks Equity .

Stock Equity | January 31, 2023

Onconova Therapeutics Inc. (ONTX) can excel with these strategies

Onconova Therapeutics Inc. (NASDAQ:ONTX) closed Monday at $1.12 per share, up from $0.85 a day earlier. While Onconova Therapeutics Inc. has overperformed by 31.61%, investors are advised to look at stock chart patterns for technical insight. Within its last year performance, ONTX fell by -33.33%, with highs and lows ranging from $2.06 to $0.62, whereas […]

US Post News | January 31, 2023

Onconova Therapeutics Announces Participation in the Channelchek Takeaway Series

NEWTOWN, Pa., Jan. 26, 2023 (GLOBE NEWSWIRE) -- Onconova Therapeutics, Inc. (NASDAQ: ONTX), a clinical-stage biopharmaceutical company focused on discovering and developing novel products for patients with cancer, today announced their participation in the Channelchek Takeaway Series from the J.P.Morgan Healthcare Conference, to be broadcast Thursday, January 26, starting at 10:00 EST.

GlobeNewswire | January 26, 2023

Read More 'ONTX' Stories Here

ONTX Price Returns

1-mo 63.89%
3-mo 77.60%
6-mo -10.44%
1-year -35.16%
3-year -83.95%
5-year -99.51%
YTD 82.75%
2022 -74.68%
2021 -63.50%
2020 21.62%
2019 -81.85%
2018 -90.62%

Continue Researching ONTX

Want to see what other sources are saying about Onconova Therapeutics Inc's financials and stock price? Try the links below:

Onconova Therapeutics Inc (ONTX) Stock Price | Nasdaq
Onconova Therapeutics Inc (ONTX) Stock Quote, History and News - Yahoo Finance
Onconova Therapeutics Inc (ONTX) Stock Price and Basic Information | MarketWatch

Get Free Updates

Join thousands of investors who get the latest news, insights and top rated picks from StockNews.com!


Page generated in 0.779 seconds.